EP0182061A1 - Verfahren zur Herstellung von 2-(4-Fluorphenyl)-alpha-methyl-5-benzoxazolessigsäure - Google Patents

Verfahren zur Herstellung von 2-(4-Fluorphenyl)-alpha-methyl-5-benzoxazolessigsäure Download PDF

Info

Publication number
EP0182061A1
EP0182061A1 EP85112699A EP85112699A EP0182061A1 EP 0182061 A1 EP0182061 A1 EP 0182061A1 EP 85112699 A EP85112699 A EP 85112699A EP 85112699 A EP85112699 A EP 85112699A EP 0182061 A1 EP0182061 A1 EP 0182061A1
Authority
EP
European Patent Office
Prior art keywords
fluorophenyl
benzoxazole
acetic acid
ethyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP85112699A
Other languages
English (en)
French (fr)
Other versions
EP0182061B1 (de
Inventor
Roberto Signorini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ravizza SpA
Original Assignee
Ravizza SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ravizza SpA filed Critical Ravizza SpA
Priority to AT85112699T priority Critical patent/ATE70832T1/de
Publication of EP0182061A1 publication Critical patent/EP0182061A1/de
Application granted granted Critical
Publication of EP0182061B1 publication Critical patent/EP0182061B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals

Definitions

  • This invention relates to a new process for preparing 2(4-fluorophenyl) ⁇ -methyl-5-benzoxazole acetic acid.
  • (+)-2(4-fluorophenyl)d-methyl-5-benzoxazole acetic acid is known for example from British patent 1,495,488 and Italian patent 22454 A/82.
  • stage A 4-hydroxy-3-aminophenylacetic acid (II) is reacted with 4-fluorobenzoyl chloride (III) to produce 3(4-fluoro)-benzamido-4-hydroxyphenylacetic acid (IV).
  • the reaction is conducted in a reaction medium constituted by a 2%-5% aqueous sodium bicarbonate solution operating at a temperature of between 0° and 30°C, for a time of between 3 and 6 hours.
  • the product (IV) is obtained with a yield of about 95X.
  • stage B in which the heterocyclic ring is formed, the product (IV) is treated with a 70-80 weight 2 phosphoric acid solution at a temperature of 120°-125°C for a time of between 30 minutes and 1 hour.
  • the product (V) is obtained with a yield of between 90% and 95%.
  • stage C) the product (V) is esterified by treatment with ethyl alcohol in the presence of H 2 S0 4 , by heating under reflux for some hours to obtain ethyl (4-fluorophenyl)5-benzoxazole acetate (VI) with a yield of 80%-85%.
  • stage D) the ester (VI) is reacted with diethyloxalate in the presence of sodium methylate in a reaction medium constituted by an ether or an hydrocarbon solvent.
  • a reaction medium constituted by an ether or an hydrocarbon solvent.
  • the mixture is heated to boiling under reflux for 20-30 hours and is then cooled and neutralised with a 5% H 2 SO 4 solution.
  • the organic phase is washed with a saturated NaCl solution and then with H 2 0 and dried by treatment with Na 2 SO 4' after which it is concentrated to a small volume to obtain ethyl 2(4-fluorophenyl)-5-benzoxazole oxalacetate (VII) with a yield of between 90% and 95%.
  • stage E the product (VII) is treated with formaldehyde in an aqueous K 2 CO 3 solution at ambient temperature under agitation, for a time of 4-6 hours.
  • Ethyl 2(4-fluorophenyl)5-benzoxazole acrylate (VIII) is thus obtained, with a yield exceeding 95%.
  • stage F the ester (VIII) is hydrolysed to obtain the corresponding acid by firstly treating it in a tetrahydrofuran solution with a KOH solution at ambient temperature for 20-30 hours and then acidifying with a solution of HCl in t-butylmethylether.
  • stage G the product (IX) is hydrogenated under atmospheric pressure at a temperature of 25°-40°C, using 5% Pd-on-carbon as catalyst in a reaction medium constituted by ethyl alcohol.
  • the catalyst is separated by filtration in a nitrogen environment, and the aqueous solution is used for the reaction with 4-fluorobenzoyl chloride, which is carried out in the following manner: the aqueous solution is cooled to 5°C in a nitrogen environment, 460 ml of t-butylmethylether are added, and then 74 ml of 4-fluorobenzoyl chloride dissolved in 170 ml of t-butylmethylether are fed slowly.
  • the mixture is agitated vigorously for 6 hours at ambient temperature, after which it is filtered to recover the product. A further small quantity of product is recovered from the mother liquors by evaporating the solvent.
  • the resultant mixture is heated to boiling under reflux for 24 hours, and is then cooled and neutralised with 5X sulphuric acid.
  • the organic phase is washed firstly with a saturated sodium chloride solution and then with water, and is finally dried by treatment with sodium sulphate.
  • the mixture is agitated for 5 hours at ambient temperature and is then extracted with t-butylmethylether.
  • the solution is partly evaporated under vacuum at 40°C, cooled to ambient temperature, 500 ml of t-butylmethylether are added, and the mixture acidified with dilute (1:10) HC1 to pH 2.
  • the ether phase is separated, and the aqueous phase is extracted twice with ether.
  • the pooled ether solution is dried and evaporated. The residue is taken up in diisopropylether.
  • the catalyst is separated by filtration, and the solution is concentrated to a small volume.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP85112699A 1984-10-22 1985-10-07 Verfahren zur Herstellung von 2-(4-Fluorphenyl)-alpha-methyl-5-benzoxazolessigsäure Expired - Lifetime EP0182061B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT85112699T ATE70832T1 (de) 1984-10-22 1985-10-07 Verfahren zur herstellung von 2-(4-fluorphenyl)alpha-methyl-5-benzoxazolessigs|ure.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2326484 1984-10-22
IT23264/84A IT1177017B (it) 1984-10-22 1984-10-22 Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico

Publications (2)

Publication Number Publication Date
EP0182061A1 true EP0182061A1 (de) 1986-05-28
EP0182061B1 EP0182061B1 (de) 1991-12-27

Family

ID=11205428

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85112699A Expired - Lifetime EP0182061B1 (de) 1984-10-22 1985-10-07 Verfahren zur Herstellung von 2-(4-Fluorphenyl)-alpha-methyl-5-benzoxazolessigsäure

Country Status (6)

Country Link
US (1) US4652654A (de)
EP (1) EP0182061B1 (de)
JP (1) JPS61100574A (de)
AT (1) ATE70832T1 (de)
DE (1) DE3585022D1 (de)
IT (1) IT1177017B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1233836B (it) * 1988-01-13 1992-04-21 Euroresearch Srl Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato.
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
SK45497A3 (en) * 1994-10-12 1997-10-08 Euro Celtique Sa Benzoxazoles, pharmaceutical composition containing them and their use
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
AU4527996A (en) * 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
ATE327216T1 (de) 1997-02-03 2006-06-15 Fuji Photo Film Co Ltd Silberhalogenid enthaltendes farbphotographisches material, phenidonverbindungen zu seiner herstellung und verfahren zur herstellung dieser phenidonverbindungen
KR20120016651A (ko) * 2009-05-15 2012-02-24 사노피 Tafia의 억제제로서 유용한 화합물의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962452A (en) * 1972-05-18 1976-06-08 Lilly Industries, Ltd. Benzoxazole derivatives as therapeutics
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
US4025636A (en) * 1973-10-23 1977-05-24 Lilly Industries, Ltd. 2-(Optionally substituted)phenyl-5 or 6-substituted benzoxazoles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HELVETICA CHIMICA ACTA, vol. 57, no. 8, 18th December 1974, pages 2487-2492, Basel, CH; A.P. STOLL et al.: "Asymetrische homogene Hydrierung am Beispiel der Hydrierung eines Thiophenderivates" *
JOURNAL OF MEDICINAL CHEMISTRY, vol. 18, no. 1, January 1975, pages 53-58, Washington, DC., US; D.W. DUNWELL et al.: "2-Aryl-5-benzoxazolealkanoic acid derivatives with notable antiinflammatory activity" *

Also Published As

Publication number Publication date
DE3585022D1 (de) 1992-02-06
IT8423264A0 (it) 1984-10-22
IT1177017B (it) 1987-08-26
JPH0368026B2 (de) 1991-10-25
IT8423264A1 (it) 1986-04-22
US4652654A (en) 1987-03-24
EP0182061B1 (de) 1991-12-27
JPS61100574A (ja) 1986-05-19
ATE70832T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
US4652654A (en) Process for preparing 2(4-fluorophenyl)alpha-methyl-5-benzoxazole acetic acid
DE1938513B1 (de) Verfahren zur Herstellung von D-threo-1-p-Methylsulfonyl-phenyl-2-dichloracetamido-propan-1,3-diol
EP0153615B1 (de) Verfahren zur Herstellung von Tetronsäure
US4228299A (en) Chemical process for preparing alkyl esters or the amide of 3-(β,.beta.
US4385186A (en) Optically active 4-hydroxy-3-methyl-2-(2-propynyl)-2-cyclopentenone
EP0169688B1 (de) Verfahren zur Herstellung von antiinflammatorisch wirksamen Cycloalkylidenmethylphenylsäurederivaten
US4665197A (en) Process for preparing azetidine derivatives and intermediates thereof
US4073798A (en) Preparation of ethylamine derivatives
EP0349217A2 (de) Verfahren zur Herstellung von Bronopol
CH635063A5 (de) Verfahren zur herstellung von phenylglyoxylsaeureestern.
US4022803A (en) Process for preparing isocitric acid, alloisocitric acid and lactones thereof
EP0115406B1 (de) Verfahren zur Herstellung von Methyl-2-Tetradecyl-Glycidat
US2859239A (en) Acrylic acid compounds
EP0163926B1 (de) Verfahren zur Herstellung von Acemetacin
KR100219994B1 (ko) 글리세르알데하이드-3-펜타나이드 및 이의 제조방법
US4304942A (en) Producing substituted 2-cyclopentenones
JP2561480B2 (ja) 4,6−ジアルコキシ−2−アルキルチオピリミジン類の製造方法
US3972922A (en) Process for preparing ether tricarboxylates
EP0040478A1 (de) Verfahren zur Herstellung von Pyridin-Derivaten sowie in dem Verfahren verwendete Zwischenprodukte
DE69928123T2 (de) Ester von 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionsäure als zwischenprodukte
KR910002282B1 (ko) 인덴 아세틱산 유도체의 제조방법
DE69908169T2 (de) Verfahren zum herstellen von alpha-arylalkansäuren
DE3237632A1 (de) Verfahren zur herstellung langkettiger linearer wachsalkohole
RU1679760C (ru) 1r,3s-2,2-диметил-3-(2-метил-2-оксипропил)циклопропанкарбонитрил как промежуточное соединение в синтезе пиретроидного инсектицида - дельта-метрина и способ получения промежуточного соединения
SU904295A1 (ru) Способ получени 3-[имидазо(1,2- @ )бензимидазолил-3]акриловых кислот

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB LI LU NL SE

17P Request for examination filed

Effective date: 19860910

17Q First examination report despatched

Effective date: 19890309

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE FR GB LI LU NL SE

REF Corresponds to:

Ref document number: 70832

Country of ref document: AT

Date of ref document: 19920115

Kind code of ref document: T

REF Corresponds to:

Ref document number: 3585022

Country of ref document: DE

Date of ref document: 19920206

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19921031

26N No opposition filed
REG Reference to a national code

Ref country code: FR

Ref legal event code: CD

EAL Se: european patent in force in sweden

Ref document number: 85112699.5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20010913

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20010914

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20010921

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20011005

Year of fee payment: 17

Ref country code: FR

Payment date: 20011005

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20011030

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20011113

Year of fee payment: 17

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20020103

Year of fee payment: 17

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021007

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021007

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021008

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021031

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021031

BERE Be: lapsed

Owner name: *RAVIZZA S.P.A.

Effective date: 20021031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030501

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030501

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20021007

EUG Se: european patent has lapsed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030630

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20030501

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST